Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionTwo Sigma Advisers, Lp
Latest Disclosed Ownership1,864,651 shares
Latest Disclosed Value $ 6,544,925
Two Sigma Advisers, Lp reports 3.84% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On February 17, 2026 - Two Sigma Advisers, Lp filed a 13F-HR form disclosing ownership of 1,864,651 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $5,135,249 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 1,795,751 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 3.84% during the quarter. The current value of the position is $4,549,748 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,864,651 68,900 3.84 6,545 11.79 0.0127
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,795,751 305,500 20.50 5,854 60.34 0.0117
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,490,251 1,490,251 3,651 0.0075
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -10,845 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 10,845 -5,200 -32.41 136 -54.05 0.0003
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 16,045 -12,800 -44.38 296 -52.33 0.0007
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 28,845 -48,731 -62.82 621 -70.27 0.0014
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 77,576 -33,000 -29.84 2,090 -36.95 0.0048
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 110,576 -75,175 -40.47 3,314 -12.95 0.0078
2023-11-14 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 185,751 -42,700 -18.69 3,806 -16.15 0.0097
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 228,451 -156,200 -40.61 4,539 -31.11 0.0116
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 384,651 -63,200 -14.11 6,589 -24.82 0.0170
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 447,851 16,400 3.80 8,764 27.27 0.0245
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 431,451 78,800 22.35 6,886 41.92 0.0199
2022-08-15 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 352,651 78,800 28.77 4,852 11.72 0.0138
2022-05-16 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 273,851 57,200 26.40 4,343 -8.16 0.0115
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 216,651 22,200 11.42 4,729 -18.63 0.0118
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 194,451 18,400 10.45 5,812 -25.46 0.0151
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 176,051 -7,200 -3.93 7,797 -4.11 0.0206
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 183,251 148,175 422.44 8,131 322.61 0.0223
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 35,076 18,270 108.71 1,924 401.04 0.0051
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 16,806 2,100 14.28 384 24.68 0.0011
2020-09-15 2020-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 14,706 14,706 308 0.0009
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 14,706 14,706 308 890.0177
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -8,600 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 8,600 8,600 212 0.0005
2016-08-15 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -38,300 -100.00 0 -100.00
2016-05-16 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 38,300 -25,100 -39.59 283 -60.58 0.0016
2016-02-16 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 63,400 -16,400 -20.55 718 -6.02 0.0043
2015-11-16 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 79,800 79,800 764 0.0048
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.